Search results for: 'Merger and Acquisition Terms and Agreements in Pharma'

Did you mean: medgen and acquisition texas and agreements in pharma

Related search terms: merger+and+acquistions; Acquisition Terms and Agreements in Pharma; merger and acquisition texas and agreements; merger+and+acquisition+deal+and+alliances+of+2014; merger+and+acquisition+deal+and+alliance+of+2015

Current Agreements 12 Month Access
November 2024

$5,995.00

Add to Wish List Add to Compare

Powerful Intelligence for Dealmakers...

Leading deals and alliances database for the life sciences sector
Learn More
Hematology Collaboration and Licensing Deals 2016-2024
October 2024

$3,995.00

Add to Wish List Add to Compare

Hematology Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2024
Learn More
Oncology Collaboration and Licensing Deals 2019-2024
October 2024

$3,995.00

Add to Wish List Add to Compare

Oncology Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals | Comprehensive deal directory 2019 to 2024
Learn More
Asset Purchase Deals in Pharmaceuticals, Biotechnology, Medical Devices and Diagnostics 2016 to 2024
September 2024

$3,995.00

Add to Wish List Add to Compare

Asset Purchase Deals in Pharmaceuticals and Biotechnology | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Comprehensive deal directory 2016 to 2024
Learn More
Genitourinary Collaboration and Licensing Deals 2016-2024
October 2024

$3,995.00

Add to Wish List Add to Compare

Genitourinary Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2024
Learn More
Metabolic Collaboration and Licensing Deals 2019-2024
October 2024

$3,995.00

Add to Wish List Add to Compare

Metabolic Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals | Comprehensive deal directory 2016 to 2024
Learn More
Psychiatry Collaboration and Licensing Deals 2019-2024
October 2024

$3,995.00

Add to Wish List Add to Compare

Psychiatry Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals | Comprehensive deal directory 2019 to 2024
Learn More
Royalty Rates in Pharmaceutical and Biotechnology Deals
September 2024

$3,995.00

Add to Wish List Add to Compare

Essential Benchmark Data for Dealmakers | Global coverage | Updated to 2024 | Over a decade of royalty rates | Deal financials | Contract documents | Royalty rate trends
Learn More
Cardiovascular Collaboration and Licensing Deals 2016-2024
October 2024

$3,995.00

Add to Wish List Add to Compare

Cardiovascular Collaboration and Licensing Deals | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Collaboration, licensing, development, and research deals |Comprehensive deal directory 2016 to 2024
Learn More
Option and Evaluation Deals in Pharmaceuticals and Biotechnology 2016-2024
September 2024

$3,995.00

Add to Wish List Add to Compare

Option and Evaluation Deals in Pharmaceuticals and Biotechnology | Global coverage | Deal financials | Contract documents | Deal trends | Leading dealmakers | Comprehensive deal directory 2016 to 2024
Learn More